Caris Life Sciences Income Statement (2024-2026) | CAI

Income Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 100.05M101.62M129.91M120.92M181.40M216.83M292.89M216.17M
Cost of Revenue (Quarter) 38.71M36.76M37.52M39.83M42.26M41.27M44.15M45.04M
Gross Profit (Quarter) 61.34M64.86M92.39M81.09M139.14M175.57M248.74M171.13M
Operating items
Research & Development (Quarter) 24.79M27.64M27.11M23.07M25.05M21.62M31.84M31.32M
Selling, General & Administrative (Quarter) 41.07M40.85M43.11M52.12M64.37M51.97M56.51M59.71M
Other Operating Expenses (Quarter) 101.20M93.97M96.74M103.68M109.97M110.59M116.12M119.87M
Operating Expenses (Quarter) 167.06M162.46M166.96M178.87M199.39M184.19M204.47M210.89M
Operating Income (Quarter) -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M
EBIT (Quarter) -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M
Non-operating items
Interest & Investment Income (Quarter) 2.64M1.74M0.97M0.50M1.62M7.36M7.01M6.83M
Other Non Operating Income (Quarter) -0.14M0.04M-0.03M-0.02M-18.34M-0.09M-2.11M0.05M
Non Operating Income (Quarter) -0.14M0.04M-0.03M-44.63M-53.80M-8.32M-2.11M-5.93M
Net income details
EBT (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.64M
Tax Provisions (Quarter) -0.13M
Profit After Tax (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Income from Continuing Operations (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Consolidated Net Income (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Income towards Parent Company (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Preferred Dividend Payments (Quarter) 24.66M96.37M24.46M384.44M
Net Income towards Common Stockholders (Quarter) -89.78M-92.39M-61.95M-127.04M-517.20M24.32M81.96M-0.51M
Additional items
EPS (Basic) (Quarter) -2.54-2.59-1.74-3.57-7.970.091.610.00
EPS (Weighted Average and Diluted) (Quarter) -2.54-2.59-1.74-3.57-7.970.081.610.00
Shares Outstanding (Weighted Average) (Quarter) 35.34M35.64M35.50M35.62M50.35M128.45M167.21M282.56M
Shares Outstanding (Diluted Average) (Quarter) 35.34M35.44M35.50M35.62M64.92M297.21M167.21M282.56M
EBITDA (Quarter) -66.09M-67.85M-36.94M-102.55M-71.37M24.40M82.14M-0.55M
Interest Expenses (Quarter) 13.67M13.80M13.26M12.78M19.21M13.51M11.36M12.81M
Tax Rate (Quarter) 20.81%